Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
Holding VRAX?
Track your performance easily
Virax Biolabs Group Ltd. Class A (VRAX) Ownership Overview
0.00%
Insiders
0.02% Mutual Funds
5.17% Other Institutional Investors
― ETFs
94.81% Public Companies and
Individual Investors
The ownership structure of Virax Biolabs Group Ltd. Class A (VRAX) stock is a mix of institutional, retail, and individual investors. , and 94.81% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 542 | Institution | 0.02% | 612 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 542 | Institution | 0.02% | 612 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Virax Biolabs Group Ltd. Class A (VRAX)?
According to the latest TipRanks data, approximately 5.17% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 94.81% is held by retail investors.
What percentage of Virax Biolabs Group Ltd. Class A (VRAX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.17% of Virax Biolabs Group Ltd. Class A (VRAX) stock is held by institutional investors.
What percentage of Virax Biolabs Group Ltd. Class A (VRAX) stock is held by retail investors?
According to the latest TipRanks data, approximately 94.81% of Virax Biolabs Group Ltd. Class A (VRAX) stock is held by retail investors.
Who owns the most shares of Virax Biolabs Group Ltd. Class A (VRAX)?
Fidelity Concord Street Trust owns the most shares of Virax Biolabs Group Ltd. Class A (VRAX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.